Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
5.7
3.0
Journals
JCM
Special Issues
Clinical Advances in Thoracic Surgery
share announcement

Clinical Advances in Thoracic Surgery

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "General Surgery".

Deadline for manuscript submissions: 31 October 2024 | Viewed by 4680

Special Issue Editor

Dr. Giacomo Cusumano

E-Mail Website
Guest Editor
Thoracic Surgery, Policlinico-San Marco Hospital, 95121 Catania, Italy
Interests: thoracic surgery; lung cancer; thymic tumors; mediastinum; robotic-assisted surgery; lung carcinoids
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

We are pleased to invite authors to contribute to this Special Issue of the Journal of Clinical Medicine titled "Clinical Advances in Thoracic Surgery". The aim of this issue is to thoroughly explore new developments in thoracic surgery, providing a platform for groundbreaking research and collaborative insights.

The following are some suggestions for key focus areas:

New technologies: We welcome papers that investigate the unclear aspects of robotics and minimally invasive surgery, shedding light on potential new therapeutic targets, and share insights into evolving techniques and their clinical outcomes.

  • Artificial intelligence applications: We encourage the submission of papers that investigate the latest developments in artificial intelligence and their potential applications in diagnosis and surgical therapies, paving the way for more standardized protocols and personalized treatments.
  • Results of conservative surgery: Contributions to the discourse surrounding the short- and long-term outcomes and comparative effectiveness of sublobar resections are encouraged, as are those that enhance our understanding of optimal treatment strategies for patients with early-stage disease.
  • Surgery beyond the limits: We welcome contributions that evaluate the impacts of new strategies on patients with severe respiratory or cardiac conditions, particularly those that examine surgery with respiratory and mechanical support systems such as ECMO, as well as new strategies for preoperative cardiac preconditioning with inodilators.
  • New challenges for thoracic surgeons: Discussions of the nuanced considerations and potential benefits of current applications of neoadjuvant immunotherapy that address perioperative challenges and risks for this demographic are welcome.

This Special Issue provides a platform within the prestigious Journal of Clinical Medicine that facilitates global visibility and collaboration, and aims to assemble a community of experts dedicated to unraveling the complexities of thoracic surgery to positively impact patient care.

We invite authors to submit original research articles, reviews, and clinical studies that demonstrate groundbreaking work, novel methodologies, and clinical experiences, with the aim of advancing knowledge in these fields.

Dr. Giacomo Cusumano
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • thoracic surgery
  • lung cancer
  • thoracoscopic ablation
  • thoracic surgical oncology
  • thymic tumors
  • robotic surgery
  • lung carcinoids
  • thoracic trauma
  • oncological treatment

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (3 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Review

Jump to: Other

12 pages, 8355 KiB  
Review
Re-Expansion Pulmonary Edema as a Life-Threatening Complication in Massive, Long-Standing Pneumothorax: A Case Series and Literature Review
by Giacomo Cusumano, Luigi La Via, Alberto Terminella and Massimiliano Sorbello
J. Clin. Med. 2024, 13(9), 2667; https://doi.org/10.3390/jcm13092667 - 2 May 2024
Viewed by 2936
Abstract
Re-expansion pulmonary edema is a rare and potentially life-threatening complication that can occur after the rapid re-expansion of a collapsed lung due to pneumothorax or pleural effusion. It has a multifactorial pathogenesis, and risk factors for re-expansion pulmonary edema, such as chronic lung [...] Read more.
Re-expansion pulmonary edema is a rare and potentially life-threatening complication that can occur after the rapid re-expansion of a collapsed lung due to pneumothorax or pleural effusion. It has a multifactorial pathogenesis, and risk factors for re-expansion pulmonary edema, such as chronic lung collapse, rapid re-expansion, and changes in pulmonary vascular permeability, have been identified. Clinical manifestations vary, ranging from almost asymptomatic to a rapidly fatal condition, and its incidence may be more common and less fatal than previously believed. The literature emphasizes the importance of early recognition and management to ensure favorable outcomes. However, there is ongoing debate regarding the indications for ventilatory support and the timing of non-invasive or invasive ventilation. Herein, we report a case series of three paradigmatic examples of massive re-expansion pulmonary edema occurring over a period of 10 years in our institution among a population of 815 patients with spontaneous pneumothorax. We also conducted a literature review on re-expansion pulmonary edema, with a particular focus on diagnosis and management. In each case, despite initially normal clinical parameters, severe respiratory distress developed following the insertion of a thoracic drainage tube for a massive spontaneous pneumothorax. Two patients required High-Flow Nasal Oxygen, and one was addressed to intensive management, including CPAP. In all cases, the patient’s outcome was optimal. Full article
(This article belongs to the Special Issue Clinical Advances in Thoracic Surgery)
►▼ Show Figures

Figure 1

Other

Jump to: Review

11 pages, 1629 KiB  
Systematic Review
Rib Hemangiomas: Intriguing Findings from a Systematic Review of Rare Thoracic Tumors
by Jayant Kumar, Jonathan Magloire, Luis Quintero, Deep Vakil, Himani Bhatt, Noor Kassira, Tamar Levene and Holly Neville
J. Clin. Med. 2024, 13(18), 5586; https://doi.org/10.3390/jcm13185586 - 20 Sep 2024
Viewed by 472
Abstract
Background: Bone hemangiomas are rare benign vascular tumors, comprising less than 1% of all bone tumors. They are predominantly found in the vertebral body or skull; rib hemangiomas are particularly rare and are often misdiagnosed as malignant tumors. Given the high malignancy rate [...] Read more.
Background: Bone hemangiomas are rare benign vascular tumors, comprising less than 1% of all bone tumors. They are predominantly found in the vertebral body or skull; rib hemangiomas are particularly rare and are often misdiagnosed as malignant tumors. Given the high malignancy rate of primary rib tumors, understanding rib hemangiomas is crucial to avoid misdiagnosis. Methods: A systematic review was conducted according to PRISMA standards. A comprehensive literature search was performed in PubMed, EMBASE, Web of Science, and Scopus. Data on patient demographics, tumor characteristics, and clinical presentation were analyzed using STATA/SE 17. Results: From 306 articles, 40 studies including 43 patients met the inclusion criteria. Rib hemangiomas showed a bimodal age distribution, with peaks in patients younger than 30 years (mean age 21.43 ± 5.60 years) and ≥30 years (mean age 59.96 ± 9.70 years). Females were more affected (62.79%) than males (37.21%), with a ratio of 1.69:1. The tumors were most frequently located in mid-thoracic ribs (4–8) and predominantly on the left side of the thorax. The mean tumor size was 7.27 cm, with 76.19% exhibiting osteolytic changes. Clinically, 63.41% of cases were asymptomatic, while symptomatic cases mainly presented with pain. Conclusions: Rib hemangiomas, though rare, should be considered in the differential diagnosis of thoracic tumors. They present as well-demarcated lytic lesions with distinct imaging features, and they typically require complete surgical excision, which may be aided with preoperative embolization. Their accurate diagnosis involves a combination of radiologic and clinical evaluation. Further studies are needed to understand the disease’s pathophysiology and to refine diagnostic and treatment protocols. Full article
(This article belongs to the Special Issue Clinical Advances in Thoracic Surgery)
►▼ Show Figures

Figure 1

9 pages, 217 KiB  
Essay
Artificial Intelligence Applications for Thoracic Surgeons: “The Phenomenal Cosmic Powers of the Magic Lamp”
by Giacomo Cusumano, Stefano D’Arrigo, Alberto Terminella and Filippo Lococo
J. Clin. Med. 2024, 13(13), 3750; https://doi.org/10.3390/jcm13133750 - 27 Jun 2024
Cited by 1 | Viewed by 819
Abstract
In the digital age, artificial intelligence (AI) is emerging as a transformative force in various sectors, including medicine. This article explores the potential of AI, which is akin to the magical genie of Aladdin’s lamp, particularly within thoracic surgery and lung cancer management. [...] Read more.
In the digital age, artificial intelligence (AI) is emerging as a transformative force in various sectors, including medicine. This article explores the potential of AI, which is akin to the magical genie of Aladdin’s lamp, particularly within thoracic surgery and lung cancer management. It examines AI applications like machine learning and deep learning in achieving more precise diagnoses, preoperative risk assessment, and improved surgical outcomes. The challenges and advancements in AI integration, especially in computer vision and multi-modal models, are discussed alongside their impact on robotic surgery and operating room management. Despite its transformative potential, implementing AI in medicine faces challenges regarding data scarcity, interpretability issues, and ethical concerns. Collaboration between AI and medical communities is essential to address these challenges and unlock the full potential of AI in revolutionizing clinical practice. This article underscores the importance of further research and interdisciplinary collaboration to ensure the safe and effective deployment of AI in real-world clinical settings. Full article
(This article belongs to the Special Issue Clinical Advances in Thoracic Surgery)
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-3
Back to TopTop